Etiopathogenesis of seborrheic dermatitis

Indian Journal of Dermatology, Venereology and Leprology

Volumn 72, Issue 4, 2006, Pages 253-255

  Valia, R ^a,b  

^a LOKMANYA TILAK MUNICIPAL MEDICAL COLLEGE AND GENERAL HOSPITAL   (India)

^b NONE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIFUNGAL AGENT; AURANOFIN; AUROTHIOGLUCOSE; BUSPIRONE; CHLORPROMAZINE; CIMETIDINE; ETHIONAMIDE; GOLD; GRISEOFULVIN; HALOPERIDOL; IMMUNOMODULATING AGENT; ISOTRETINOIN; KETOCONAZOLE; LEVODOPA; LITHIUM; METHOXSALEN; METHYLDOPA; METRONIDAZOLE; PHENOTHIAZINE; PSORALEN; STANOZOLOL; STEROID; TIOTIXENE; TRIOXYSALEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; EDITORIAL; ESSENTIAL FATTY ACID DEFICIENCY; HUMAN; INFLAMMATION; NICOTINIC ACID DEFICIENCY; PATHOGENESIS; PITYROSPORUM OVALE; PYRIDOXINE DEFICIENCY; RIBOFLAVIN DEFICIENCY; SEBORRHEIC DERMATITIS; ZINC DEFICIENCY;

EID: 33746862948     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: 10.4103/0378-6323.26711     Document Type: Editorial

References (33)

1. Burton JL, Pye RJ. Seborrhea is not a feature of seborrheic dermatitis. BMJ 1983;286:1169-971.
2. Binder RL, Jonelis FJ. Seborrheic dermatitis in neurolepticinduced Parkinsonism. Arch Dermatol 1983;119:473-5.
3. Burton JL, Cartilidge M, Shuster S. Effect of L-dopa on the seborrhea of Parkinsonism. Br J Dermatol 1973;88:475-9.
4. th ed. New York: McGraw-Hill; 2003. p. 1204.
5. Henderson CA, Taylor J, Cunliffe WJ. Sebum excretion rates in mothers and neonates. Br J Dermatol 2000;142:110-1.
6. Leung AK. Neonatal seborrheic dermatitis (letter). West J Med 1985;142:558-62.
7. Schechtman RC, Midgley G, Bingham JS, Hay RJ. Progress of seborrheic dermatitis. Br J Dermatol 1995;133:537-45.
8. Neville EA, Finn OA. Psoriasiform napkin dermatitis: A follow-up study. Br J Dermatol 1975;92:279-85.
9. Podmore P, Burrows D, Eady DJ, Stanford CF. Seborrheic dermatitis: Disease entity or a clinical variant of atopic dermatitis? Br J Dermatol 1986;115:341-50.
10. Cohen S. Should we treat infantile seborrheic dermatitis with topical antifungals or topical steroids? Arch Dis Child 2004;89:288-9.
11. Schusten S, Blatchford N. Seborrheic dermatitis and dandruff - A fungal disease. Royal Soc Med Services 1988;132:1-54.
12. Crespo EV, Delgado FV. Malassezia species in skin disease. Curr Opin Infect Dis 2002;15:133-42.
13. Faergemann J, Fredriksson T. Tinea versicolor with reference to seborrheic dermatitis. Arch Dermatol 1979;115:966-8.
14. Back O, Faergemann J, Hornqvist R. Pityrosporum folliculitis: A common disease of the young and middle-aged. J Am Acad Dermatol 1985;12:56-61.
15. Heng MC, Henderson CL, Barker DC, Haberfelde G. Correlation of Pityrosporum ovale density with clinical severity of seborrheic dermatitis as assessed by a simplified technique. J Am Acad Dermatol 1990;23:82-6.
16. McGinley KJ, Leyden JJ, Marples RR, Kligman AM. Quantitative microbiology of the scalp in non-dandruff, dandruff and seborrhoeic dermatitis. J Invest Dermatol 1975;64:401-5.
17. Wattanbe S, Kano R, Sato H, Nakamura Y, Hasegawa A. The effect of Malassezia yeasts on cytokine production by human keratinocytes. J Invest Dermatol 2001;116:769-73.
18. Bergbrant IM. Seborrheic dermatitis and pityrosporum yeasts. Curr Top Med Mycol 1995;6:95-112.
19. Pye RJ, Meyrick G, Burton JL. Skin surface in seborrheic dermatitis. Br J Dermatol 1977;97:12-4.
20. Tolesson A, Frithz A, Berg A, Karlman G. Essential fatty acids in infantile seborrheic dermatitis. J Am Acad Dermatol 1993;28:957-61.
21. Ostlers LS, Taylor CR, Harris DW, Rustin MH, Wright S, Johnson M. Surface lipids in HIV positive patients with and without seborrheic dermatitis. Br J Dermatol 1996;35:276-9.
22. Bergbrant IM, Johansson S, Robbins D, Scheynius A, Faergemann J, Soderstrom T. An immunological study in patients with seborrheic dermatitis. Clin Exp Dermatol. 1991;16:331-8.
23. Parry ME, Sharpe GR. Seborrheic dermatitis is not caused by an altered immune response to Malassezia yeast. Br J Dermatol 1998;139:254-63.
24. Wilker JR. Cell mediated deficiency in Pityrosporum orbiculare in patients with seborrheic dermatitis (abstract). J Invest Dermatol 1989;92:241-5.
25. Neuber K, Kroger S, Gruseek E, Abeck D, Ring J. Effect of proliferation, immunoglobulin (IgA, IgG, IgM) synthesis and cytokine (IL2, IL10, IFN-α) production of peripheral blood mononuclear cells from seborrheic dermatitis. Arch Dermatol Res 1996;288:532-6.
26. Faergemann J, Jones JC, Hettler O, Loria Y. Pityrosporum ovale (Malassezia furfur) as the causative agent of seborrheic dermatitis: New treatment options. Br J Dermatol 1996;134:12-5.
27. Berger RS, Stoner MF, Hobbs ER, Hayes TJ, Boswell RN. Cutaneous manifestations of human immunodeficiency virus exposure. J Am Acad Dermatol 1988;19:298-303.
28. Marino CT, McDonald E, Romano JF. Seborrheic dermatitis in acquired immunodeficiency syndrome. Cutis 1991;50:217-8.
29. Kaplan MH, Sadick N, McNutt NS. Dermatologic findings and manifestations of acquired immunodeficiency syndrome (AIDS). J Am Acad Dermatol 1989;20:770-3.
30. Selden S. Seborrheic dermatitis. http://www.emedicine.com/derm/topic396. htm Last updated: September 23, 2005. Last accessed: June 12, 2006.
31. nd edn. Bombay: Bhalani Publishing House, 1999. p. 974-1001.
32. Cunha PR. Pimecrolimus cream 1% is effective in seborrheic dermatitis refractory to treatment with topical corticosteroids. Act Derm Venerol 2006;86:69-70.
33. Siadat AH, Iraji F, Shahmoradi Z, Enshaieh S, Taheri A. The efficacy of 1% metronidazole gel in facial seborrheic dermatitis: A double blind study. Indian J Dermatol Venerol Leprol 2006;72:266-9.